RM

Roan Martin

Vice President, Quality Compliance at X4 Pharmaceuticals

Roan Martin has extensive work experience in quality assurance and compliance roles in the pharmaceutical industry. Roan has held positions at various companies, including X4 Pharmaceuticals, Blueprint Medicines, Alnylam Pharmaceuticals, PAREXEL, and FARMOVS Research Centre.

At X4 Pharmaceuticals, Roan served as the Vice President of Quality Compliance, responsible for managing the auditing Quality Management System, leading Inspection Readiness efforts, and coordinating regulatory inspections. Roan also conducted audits of external service providers.

Prior to that, at Blueprint Medicines, Roan worked as a Senior Director of Quality Assurance, overseeing GCP and GcLP activities and managing the QA team. Roan also coordinated regulatory inspections and addressed quality issues.

At Alnylam Pharmaceuticals, Roan served as a Senior Director of Quality Assurance, responsible for GCP, GcLP, and GLP activities. Roan managed the respective QA teams, conducted audits, and coordinated regulatory inspections.

At PAREXEL, Roan held multiple roles, including Senior Director, Head of Quality Assurance. Roan was responsible for global quality assurance activities, managing multinational teams, and coordinating regulatory inspections. Roan also served as the Senior Director of the Sponsor Audit and Inspection Group, providing guidance and support for audit activities.

Before joining PAREXEL, Roan worked at FARMOVS Research Centre as a Quality Assurance Auditor and Clinical Research Associate. Roan conducted audits, liaised with divisions, and performed various tasks related to clinical research.

In summary, Roan Martin has a wealth of experience in quality assurance, compliance, auditing, and regulatory inspection coordination in the pharmaceutical industry.

Roan Martin has a Diploma of Credit in Research Quality Assurance from Anglia Polytechnic University, Cambridge (UK). Roan also has a BMedSc Hons degree in Pharmacology, a BSc degree in Psychology and Physiology, and is currently studying Medicine up to the 4th year at the University of the Free State.

Links

Previous companies

Alnylam Pharmaceuticals logo
Blueprint Medicines logo
Parexel logo

Org chart

Timeline

  • Vice President, Quality Compliance

    January, 2023 - present

  • Senior Director, R&d Quality

    January, 2021

  • Director R&d Quality

    March, 2020

View in org chart